Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06272786

Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair

Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .. Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ahi Evran University

Kirşehir, City Centre, 40100, Turkey (Türkiye)

Location status: Recruiting

Location contact

Basak Cigdem Karacay, Assist Prof

CONTACT

[email protected]

:+90 386 280 39 00

Basak Cigdem Karacay, Assist Prof

PRINCIPAL_INVESTIGATOR

About this study

Suprascapular nerve block is an injection method that has been shown to be effective in shoulder rehabilitation in diseases such as adhesive capsulitis and stroke .Applying the block under USG guidance instead of blinding increases the effectiveness and reduces complications There are many studies in the literature on suprascapular, axillary, and interscalene nerve blocks in early pain management after shoulder arthroplasty. All of these focus on pain in the perioperative or early postoperative period. There is a study on USG-guided suprascapular nerve block. In this study, unlike the studies in the literature, it was aimed to show the effectiveness of USG-guided suprascapular nerve block in the subacute rehabilitation process of patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Having undergone arthroscopic rotator cuff repair surgery within the last week

Exclusion criteria

  • History of previous surgery on the same shoulder
  • History of systemic inflammatory rheumatological disease
  • Neurological diseases with muscle weakness in the upper extremity (MS, ALS, Muscular -Dystrophy)
  • History of malignancy, pregnancy, breastfeeding
  • Use of steroids or immunosuppressive drugs
  • History of allergic reactions to local analgesics
  • Fibromyalgia syndrome
  • Chronic painful conditions that require opioid use
  • Presence of known psychiatric disease
  • Cognitive impairment (Mini Mental Test Score <23)

Treatment and study plan

conventional physiotherapy program.

Procedure

It will be applied to a rehabilitation program including joint range of motion exercises and physical therapy modalities by a physiotherapist at the Physical Therapy Hospital.

Suprascapular nerve block

Procedure

Bupivacaine hydrochloride will be used in this injection. 5 ml of bupivacaine hydrochloride 5% and 5 ml of saline will be drawn into a 10 ml syringe and ejection will be performed from the superior of the suprascapular noch under USG guidance.

Primary outcomes

  1. Visual Analog Scale (VAS)

    Time frame: Baseline

    In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.

  2. Visual Analog Scale (VAS)

    Time frame: 6th week

    In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.

  3. Visual Analog Scale (VAS)

    Time frame: 10th week

    In the study, pain intensity was evaluated with the Visual Analogue Scale (VAS). Numbers from 0 to 10 on VAS; Patients will be asked to score their pain levels at rest, activity and at night, with 0 being defined as "no pain" and 10 being "unbearable pain". Increased scores indicate higher pain intensity.

  4. Shoulder joint range of motion (ROM)

    Time frame: Baseline

    Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.

  5. Shoulder joint range of motion (ROM)

    Time frame: 6th week

    Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.

  6. Shoulder joint range of motion (ROM)

    Time frame: 10 th week

    Joint range of motion will be measured and recorded passively in all directions using a goniometer according to the neutral zero method.

Secondary outcomes

  1. Shoulder Pain and Disability Index (SPADİ)

    Time frame: Baseline

    SPADI is a scale consisting of a total of 13 questions with 2 subscales: pain and disability. The score of the total and all sub-parameters is evaluated on a scale of 0-100. A high score indicates increased pain and impaired shoulder function.

  2. Shoulder Pain and Disability Index (SPADİ)

    Time frame: 6th week

    SPADI is a scale consisting of a total of 13 questions with 2 subscales: pain and disability. The score of the total and all sub-parameters is evaluated on a scale of 0-100. A high score indicates increased pain and impaired shoulder function.

  3. Shoulder Pain and Disability Index (SPADİ)

    Time frame: 10th week

    SPADI is a scale consisting of a total of 13 questions with 2 subscales: pain and disability. The score of the total and all sub-parameters is evaluated on a scale of 0-100. A high score indicates increased pain and impaired shoulder function.

  4. Modified Constant-Murley Scoring

    Time frame: 6th week

    Modified Constant-Murley Scoring includes a total of four parameters: pain, activities of daily living (ADL), active ROM and strength. The total score is evaluated on a scale of 0-100 points by summing all subparametricS. A low score reflects increased pain and impaired shoulder functions, both in terms of subparametrics and the total score.

  5. Modified Constant-Murley Scoring

    Time frame: 10th week

    Modified Constant-Murley Scoring includes a total of four parameters: pain, activities of daily living (ADL), active ROM and strength. The total score is evaluated on a scale of 0-100 points by summing all subparametricS. A low score reflects increased pain and impaired shoulder functions, both in terms of subparametrics and the total score.

  6. Modified Constant-Murley Scoring

    Time frame: Baseline

    Modified Constant-Murley Scoring includes a total of four parameters: pain, activities of daily living (ADL), active ROM and strength. The total score is evaluated on a scale of 0-100 points by summing all subparametricS. A low score reflects increased pain and impaired shoulder functions, both in terms of subparametrics and the total score.

Study contacts

Contact information is provided by the study sponsor or research team.

Basak Cigdem Karacay, Asst Prof

CONTACT

[email protected]

+9 0386 280 51 00.

Sponsors and collaborators

Lead sponsor

Kirsehir Ahi Evran Universitesi

Other

Registry information

Official study title

The Effect of Suprascapular Nerve Block in Patients Rehabilitated After Arthroscopic Rotator Cuff Repair: Randomized Controlled Study

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Feb 22, 2024
Registry last updated
Aug 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.